First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry


Droz J., Efstathiou E., Yildirim A., Cabrera P., Kim C. S. , Horchani A., ...More

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, vol.34, no.5, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 34 Issue: 5
  • Publication Date: 2016
  • Doi Number: 10.1016/j.urolonc.2015.12.005
  • Title of Journal : UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Abstract

Aims: To compare the efficacy and tolerability of taxane and nontaxane therapy in senior adults with chemonaive metastatic castration resistant prostate cancer (mCRPC), and examine the effect of patient health status on outcomes.